Diazepam vs Lorazepam
Clinical Comparison
Clinical Context
Both are benzodiazepines used in acute settings. Lorazepam is NICE first-line IV treatment for status epilepticus due to its predictable duration and lack of active metabolites. Diazepam is preferred for alcohol withdrawal (smoother long-acting cover) and when rectal administration is needed (community seizure rescue).
Drug Profiles
Diazepam
Benzodiazepine (long-acting)
Mechanism
Enhances GABA-A receptor activity by binding to the benzodiazepine site, increasing chloride channel opening frequency, producing anxiolytic, sedative, anticonvulsant, and muscle-relaxant effects
Indications
- Status epilepticus (rectal or IV)
- Acute anxiety
- Alcohol withdrawal
- Muscle spasm
- Pre-procedural sedation
Common Doses
Anxiety: 2-5 mg TDS; Status epilepticus: 10 mg IV/rectal; Alcohol withdrawal: reducing regimen starting 10-20 mg QDS
Route
Oral, IV, rectal
Onset & Duration
IV onset: 1-5 min; Oral onset: 15-30 min; Half-life: 20-100 hours (including active metabolite desmethyldiazepam)
Lorazepam
Benzodiazepine (intermediate-acting)
Mechanism
Same GABA-A receptor mechanism as diazepam but with no active metabolites and direct glucuronide conjugation (Phase II metabolism only)
Indications
- Status epilepticus (first-line IV per NICE)
- Acute severe anxiety
- Pre-operative anxiolysis
- Acute psychomotor agitation
Common Doses
Status epilepticus: 4 mg IV (0.1 mg/kg); Anxiety: 0.5-1 mg BD/TDS; Pre-op: 2-4 mg
Route
Oral, IV, IM
Onset & Duration
IV onset: 2-5 min; Oral onset: 20-30 min; Half-life: 10-20 hours; No active metabolites
Key Differences
| Category | Diazepam | Lorazepam |
|---|---|---|
| Half-life | 20-100 hours (very long, with active metabolites) | 10-20 hours (no active metabolites) |
| Status epilepticus | Second-line (IV/rectal) — redistributes quickly from brain | First-line IV per NICE — stays in brain longer |
| Liver disease | Avoid — hepatic metabolism, active metabolites accumulate | Safer — Phase II conjugation only, no active metabolites |
| Alcohol withdrawal | Preferred — long-acting profile suits reducing regimens | Less commonly used (shorter duration, more dosing) |
| IM absorption | Erratic and unreliable IM absorption | Reliable IM absorption |
| Accumulation in elderly | High risk — very long half-life | Lower risk — shorter half-life, no active metabolites |
Half-life
20-100 hours (very long, with active metabolites)
10-20 hours (no active metabolites)
Status epilepticus
Second-line (IV/rectal) — redistributes quickly from brain
First-line IV per NICE — stays in brain longer
Liver disease
Avoid — hepatic metabolism, active metabolites accumulate
Safer — Phase II conjugation only, no active metabolites
Alcohol withdrawal
Preferred — long-acting profile suits reducing regimens
Less commonly used (shorter duration, more dosing)
IM absorption
Erratic and unreliable IM absorption
Reliable IM absorption
Accumulation in elderly
High risk — very long half-life
Lower risk — shorter half-life, no active metabolites
Key Advantages
Diazepam
- Rapid onset IV/rectal — good for acute seizures
- Long half-life provides smooth anxiolysis (less interdose anxiety)
- Multiple routes available
- Effective muscle relaxant
- Well-suited for alcohol withdrawal reducing regimens
Lorazepam
- No active metabolites — predictable duration
- Safer in liver disease (Phase II conjugation only)
- First-line IV for status epilepticus (NICE CG137)
- Predictable IM absorption (unlike diazepam IM)
- Shorter duration — less risk of prolonged sedation
Key Cautions
Diazepam
- Very long half-life — accumulation in elderly and liver disease
- Active metabolite (desmethyldiazepam) extends effects further
- High dependence potential
- Respiratory depression (especially with opioids)
- Paradoxical agitation in some patients
- Avoid long-term use (NICE: max 2-4 weeks)
Lorazepam
- Must be refrigerated (injectable solution)
- Dependence potential (same as all benzodiazepines)
- Respiratory depression
- Amnesia (more pronounced than diazepam)
- Requires observation after IV administration
- NICE: avoid long-term use (max 2-4 weeks)
Clinical Verdict
Lorazepam IV is first-line for status epilepticus and preferred in liver disease or elderly patients. Diazepam is preferred for alcohol withdrawal protocols and community seizure rescue (rectal route). Both should be limited to short-term use.
Medical Disclaimer: This comparison is for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare professional before making prescribing decisions. Verify all drug information with current clinical guidelines (BNF, NICE, SmPCs).
Full monographs for Diazepam & Lorazepam in the MedNext app
Complete dosing, interactions, contraindications, side effects, and more — covering 2,866 drugs with AI-powered search.
Download MedNext Formulary